Last September, a group of researchers published a review ‘Recent developments in anticancer kinase inhibitors based on the pyrazolo[3,4-d]pyrimidine scaffold’. Authors describe the list of compounds including this moiety, that appear in clinical trials and preclinical development.
Pyrazolo[3,4-d]pyrimidines have become of significant interest to the medicinal chemistry community as a scaffold for the development of kinase inhibitors to treat a range of diseases, including cancer.
We at Chemspace prepared a set of compounds based on pyrazolopyrimidine (1314 compounds) for your research!
In case of any questions just drop us a line: firstname.lastname@example.org.